StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Acumen Pharmaceuticals, Inc.
NasdaqGS:ABOS
Sector
Location
Market Cap
USD 78.75 M
Share Price
USD 1.30
Avg Daily Volume
336,868
Change (1 day)
4.00%
Change (1 year)
-43.23%
Change (YTD)
-24.42%
Acumen Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2025: -28.06
Acumen Pharmaceuticals, Inc. Interest Coverage Ratio is -28.06 for the Trailing 12 Months (TTM) ending March 31, 2025, a -19.44% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
-
Acumen Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2024 was -34.83, a -51.34% change year over year.
-
Acumen Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was -71.58, a -75.04% change year over year.
-
Acumen Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was -286.83.
Competitors
MERCK Kommanditgesellschaft auf Aktien
USD 133.90
MRK.DE
+3.46
2.66%
Tempus AI, Inc.
USD 59.60
TEM
+1.19
2.04%
Twist Bioscience Corporation
USD 38.47
TWST
-0.65
-1.66%
Apogee Therapeutics, Inc.
USD 38.57
APGE
+1.55
4.19%
Schrödinger, Inc.
USD 21.71
SDGR
+0.02
0.09%
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Novartis AG
USD 124.22
NOVN.SW
+1.53
1.24%
Abbott Laboratories
USD 133.60
ABT
+0.38
0.29%
AstraZeneca PLC
USD 144.13
AZN.L
+3.37
2.39%
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 430.73
TMO
+10.85
2.58%
Amgen Inc.
USD 300.37
AMGN
+3.85
1.30%
Boston Scientific Corporation
USD 103.86
BSX
+0.90
0.87%
Pfizer Inc.
USD 25.78
PFE
+0.22
0.86%
Gilead Sciences, Inc.
USD 114.54
GILD
+1.30
1.15%
Vertex Pharmaceuticals Incorporated
USD 479.53
VRTX
+0.56
0.12%
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
Bristol-Myers Squibb Company
USD 48.52
BMY
+0.86
1.80%
Key Data
| Date | Interest Coverage Ratio | Return on Capital Employed (ROCE) | Return on Equity (ROE) | Return on Assets (ROA) |
|---|
Competitors
MERCK Kommanditgesellschaft auf Aktien
USD 133.90
MRK.DE
+3.46
2.66%
Tempus AI, Inc.
USD 59.60
TEM
+1.19
2.04%
Twist Bioscience Corporation
USD 38.47
TWST
-0.65
-1.66%
Apogee Therapeutics, Inc.
USD 38.57
APGE
+1.55
4.19%
Schrödinger, Inc.
USD 21.71
SDGR
+0.02
0.09%
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Novartis AG
USD 124.22
NOVN.SW
+1.53
1.24%
Abbott Laboratories
USD 133.60
ABT
+0.38
0.29%
AstraZeneca PLC
USD 144.13
AZN.L
+3.37
2.39%
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 430.73
TMO
+10.85
2.58%
Amgen Inc.
USD 300.37
AMGN
+3.85
1.30%
Boston Scientific Corporation
USD 103.86
BSX
+0.90
0.87%
Pfizer Inc.
USD 25.78
PFE
+0.22
0.86%
Gilead Sciences, Inc.
USD 114.54
GILD
+1.30
1.15%
Vertex Pharmaceuticals Incorporated
USD 479.53
VRTX
+0.56
0.12%
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
Bristol-Myers Squibb Company
USD 48.52
BMY
+0.86
1.80%